(ABUS) Arbutus Biopharma complete technical analysis [charts+indicators] | Buy/Sell Arbutus Biopharma | (ABUS) share price targets
Complete technical analysis of Arbutus Biopharma (ABUS) by charts plus indicators, forecast predictions and share price targets for Arbutus Biopharma (ABUS)
Arbutus Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-12-09 View latest technical analysis
10 day averaged volume of Arbutus Biopharma is 1078510
| Date | Daily Closing Price | Open | High | Low | Volume |
| 09 Mon Dec 2024 | 3.67 | 3.69 | 3.73 | 3.65 | 0.279 times |
| 26 Tue Nov 2024 | 3.41 | 3.42 | 3.47 | 3.39 | 0.564 times |
| 26 Tue Nov 2024 | 3.41 | 3.42 | 3.47 | 3.39 | 0.564 times |
| 25 Mon Nov 2024 | 3.42 | 3.52 | 3.58 | 3.41 | 2.221 times |
| 22 Fri Nov 2024 | 3.51 | 3.47 | 3.53 | 3.45 | 0.665 times |
| 21 Thu Nov 2024 | 3.46 | 3.44 | 3.56 | 3.43 | 0.856 times |
| 20 Wed Nov 2024 | 3.44 | 3.53 | 3.54 | 3.42 | 0.581 times |
| 19 Tue Nov 2024 | 3.49 | 3.51 | 3.52 | 3.42 | 0.844 times |
| 18 Mon Nov 2024 | 3.52 | 3.64 | 3.68 | 3.49 | 0.986 times |
| 15 Fri Nov 2024 | 3.64 | 3.68 | 3.68 | 3.42 | 1.661 times |
My analysis of stock is bullish for shortterm, and stock might move up till 3.8 or till 4. Use a stoploss of 3.64 and if this stock hits its stoploss, then it can fall down till 3.46
Share price targets for Arbutus Biopharma (ABUS)
| Target Type | Value |
| Downside Target | 3.30 |
| Downside Target | 3.39 |
| Downside Target | 3.58 |
| Upside Target | 3.73 |
| Upside Target | 3.79 |
| Upside Target | 3.84 |
| Upside Target | 3.95 |
| Upside Target | 3.99 |
| Upside Target | 4.35 |
| Upside Target | 4.73 |
Intraday share price targets for Arbutus Biopharma (ABUS)
| Target Type | Value |
| Downside Intraday Target | 3.64 |
| Downside Intraday Target | 3.6 |
| Upside Intraday Target | 3.72 |
| Upside Intraday Target | 3.76 |
| Upside Intraday Target | 3.68 |
Weekly technical analysis of Arbutus Biopharma (ABUS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 09 Mon Dec 2024 | 3.67 | 3.69 | 3.73 | 3.65 | 0.494 times |
| 26 Tue Nov 2024 | 3.41 | 3.42 | 3.47 | 3.39 | 0.203 times |
| 26 Tue Nov 2024 | 3.41 | 3.52 | 3.58 | 3.39 | 0.708 times |
| 22 Fri Nov 2024 | 3.51 | 3.64 | 3.68 | 3.42 | 0.817 times |
| 15 Fri Nov 2024 | 3.64 | 3.75 | 3.84 | 3.42 | 1.016 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Arbutus Biopharma (ABUS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 09 Mon Dec 2024 | 3.67 | 3.69 | 3.73 | 3.65 | 0.016 times |
| 26 Tue Nov 2024 | 3.41 | 3.85 | 3.99 | 3.39 | 0.997 times |
| 31 Thu Oct 2024 | 3.85 | 3.81 | 4.35 | 3.65 | 0.552 times |
| 30 Mon Sep 2024 | 3.85 | 3.89 | 4.73 | 3.79 | 1.599 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Arbutus Biopharma (ABUS)
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Arbutus Biopharma stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Arbutus Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Arbutus Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Arbutus Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Arbutus Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.49 and Arbutus Biopharma (ABUS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Arbutus Biopharma (ABUS) stock. Volume based technical analysis of Arbutus Biopharma (ABUS) stock is negative.
Arbutus Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Arbutus Biopharma stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Arbutus Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Arbutus Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Arbutus Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Arbutus Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.49 and Arbutus Biopharma (ABUS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Arbutus Biopharma (ABUS) stock. Volume based technical analysis of Arbutus Biopharma (ABUS) stock is negative.
Arbutus Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.